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A number of studies have been carried out to determine the functional activity 
of polymorphonuclear leukocytes (PMN) from human neonates in an attempt to 
explain  their  unusual  susceptibility to  infection.  Although neonatal  PMN  are 
capable of ingesting and killing microorganisms (1, 2), chemotaxis of these cells 
is markedly impaired in vitro and in vivo (3-7).  The mechanism(s) involved in 
the pathogenesis of abnormal neonatal  PMN  chemotaxis are  unknown.  Miller 
(6) has reported that neonatal PMN have a decreased ability to deform following 
exposure to chemotactic stimuli, while Anderson and co-workers (7) found that 
neonatal  PMN  fail  to  form  uropods  and  to  redistribute  adhesion  sites.  The 
decreased  ability of these  cells  to change  shape  and  form  surface  projections 
suggests that the functional defect may be at  the  level of the cell  membrane. 
There does not appear to be a significant abnormality in the interaction between 
chemotactic factor and cell membrane-bound chemotactic factor receptors on 
resting neonatal PMN at 37°C (7,  8).  The defect may be,  therefore, at a  level 
beyond this initial interaction. 
The  recent  introduction  of spectrofluorometric  techniques  for  measuring 
critical ionic changes at the membrane and in the intracellular milieu has led to 
a  better  understanding of the  events associated with phagocyte activation (9- 
14).  Such  probes  include  the  cyanine  dye  3-3  dipentyloxacarbocyanine 
[DiOCs(3)],  which  is  sensitive to changes in  membrane potential  (11,  12,  15), 
and Quin  2/AM  (13,  16),  which assesses changes in intracellular free calcium. 
We have used these two fluorescent probes to assess the cellular events following 
chemotactic  factor-receptor  interaction  in  PMN  from  human  neonates  and 
compared the results with those obtained in PMN from adults. 
Materials and Methods 
PMN Preparations.  Whole blood was obtained from peripheral veins of healthy adults 
and from the umbilical cords of normal-term neonates in acid citrate dextrose (Becton 
Dickinson and Co., Rutherford, N  J). The blood was allowed to settle in  1% dextran 
(Pharmacia, Piscataway, N  J) and the PMN were separated on Ficoil-Hypaque (Pharmacia) 
gradients. Contaminating erythrocytes were hypotonicaily  lysed, and the PMN suspensions 
(98%)  were  washed  in  phosphate-buffered saline (PBS,  pH  7.4)  and  suspended  in  a 
modified Hanks' balanced salt solution (HBSS) containing 124  mM NaCI,  4  mM KCI, 
0.64 mM NaH~PO4, 0.66 mM K2HPO4,  15.2 mM NaHCOs,  10 mM Hepes buffer, 5.56 
mM glucose, and 1.6 mM CaCI2 or 2 mM EGTA. The pH was adjusted to 7.4. 
This work was supported, in part, by U. S. Public Health Service Grants AI 19094 and AI 13150 
and grants from the R. J. Reynolds Industries and the Thrasher  Research Fund. Address reprint 
requests to Fulvio  Sacchi, M.D., Division  of Clinical Immunology, Dept. of Pathology 2E500 Medical 
Center, University  of Utah, Salt Lake City, UT 84132. 
J. ExP. MED. © The Rockefeller University Press • 0022-1007/84/10]1247]06 $1.00  1247 
Volume 160  October 1984  1247-1252 1248  SACCHI  AND  HILL  BRIEF  DEFINITIVE  REPORT 
Membrane Potential Changes.  Membrane potential  changes were monitored  using a 
spectrofluorometric technique that employs the fluorescent dye DiOCs(3) (15).  100 #1 of 
10  -5 M  DiOCs(3) (Molecular Probes, Junction City, OR) were added to 2 ml of the cell 
suspension containing 5 x  108 PMN/ml. Fluorescence emission was measured over time 
using an SLM Aminco spectrofluorometer (Urbana, IL) with the excitation wave length 
set at 470 nm and the emission wavelength at 495 nm. The cells were kept in suspension 
using a magnetic stirrer, and changes in fluorescence were recorded at 1, 5, and  10 min 
after FMLP stimulation. 
Changes in  IntraceUular  Free Calcium.  Changes  in  intraceilular  free  calcium  were 
estimated using the calcium-sensitive dye Quin 2/AM (Calbiochem, LaJolla, CA) (13, 16). 
The dye was diluted in dimethyl sulfoxide (Mallinckrodt, St. Louis, MO) to a concentration 
of 10  -~ M; 2 #l of this solution was then added to 1 ml ofa PMN solution containing 108 
PMN/ml in calcium-containing HBSS. The cells were incubated for 10 min in a rotary 
shaker and then diluted 10-fold in HBSS with or without calcium and allowed to incubate 
for one hour at 37°C.  At the end of this incubation period the cells were washed and 
resuspended  (107PMN/ml)  in  calcium-containing HBSS (1.6  mM) or calcium-deprived 
HBSS to which 2 mM EGTA had been added. Fluorescence was recorded using the SLM 
Aminco spectrofluorometer with the excitation wavelength set at 339 nm and the emission 
wavelength set at 492 nm. Changes in fluorescence were recorded at 1, 2, 3, and 5 min 
after stimulation with FMLP. 
Chemotactic Factor Preparation.  Formyl-methionyl-leucyl-phenylalanine (FMLP; Sigma 
Chemical Co.,  St.  Louis,  MO) was diluted  in  PBS to  10  -5  M  and stored in aliquots at 
-70°C until use. Before each set of experiments, the solution was diluted appropriately 
in HBSS and 50 #1 was added to 2 mi of the cell suspension. Tritium-labeled FMLP was 
obtained from New England  Nuclear, Boston,  MA.  Zymosan-activated serum was pre- 
pared by incubating 10 ml of fresh human serum with 100 mg of wash zymosan (Schwarz- 
Mann, Orangeburg, NY) for 60 rain at 37°C in a rotating rack. Following centrifugation, 
the clarified activated serum was stored in aliquots at -70 ° C. For use the activated serum 
was diluted in HBSS to the appropriate concentration. 
Calcium Antagonist.  Verapamil,  a  calcium  antagonist  capable  of blocking  calcium 
channels as well as interfering with the release of stored intracellular calcium, was diluted 
in HBSS to a final concentration of 10 -4 M (17-19). 
FMLP Binding.  Total and specific FMLP binding to PMN was performed exactly as 
described by Anderson and co-workers (7). 
Results 
PMN  from  adults  had  a  marked  change  in  membrane  potential  following 
stimulation with FMLP in concentrations ranging from 10 -9 to 10 -7 M. As shown 
in Fig.  1, DiOCs(3) fluorescence emission increased 25% (P <  0.001)  1 min after 
exposure  of PMN  from  11  adults  to  2.5  x  10  -8  M  FMLP,  and  the  response 
persisted  at  5  and  l0  min.  In  striking  contrast,  PMN  from  10  normal-term 
neonates  failed to  show  any significant  change  in  DiOCs(3)  fluorescence  after 
FMLP stimulation.  Similar results were obtained when  10%  zymosan-activated 
serum containing activated C5a was employed. It should be pointed out that the 
level of fluorescence in resting, unstimulated neonatal cells exposed to DiOCs(3) 
was essentially  the  same as that  in  resting adult  PMN.  This  indicates  that  dye 
penetration  and  resting  membrane  potential  were  probably equivalent  in  the 
cells of neonates and adults.  Binding of tritiated FMLP (2.5  X  10 -8 M) to PMN 
from  9  adults  and  10  neonates  in  the  presence  or  absence  of an  excess  of 
unlabeled FMLP (10 -5 M) at 37 ° C was not significantly different. (Total binding 
in  the  absence  of unlabeled  FMLP  was  12,123  cpm  +  1,735  SE  in  adults  vs. 
9,165  cpm _+  905  in  neonates;  NSD.  Specific binding  was 8,600  cpm +  1,459 
with adult PMN vs. 7,854 +  967 in neonatal PMN; NSD.) SACCH]  AND  HILL  BRIEF  DEFINITIVE  REPORT  1249 
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FIGURE  1.  Membrane potential changes induced in PMN from 11  adults and  10 neonates 
by exposure to 9.5 X  10  -s M FMLP as determined by DiOCs(3) fluorescence emission. Data 
includes results from five experiments in which adult PMN were exposed to 10 -4 M verapamil 
for 15 min before FMLP stimulation. 
There  was no significant  difference in the responses of adult cells to FMLP 
when  calcium-deprived  media  was employed (Fig.  2).  In  contrast,  when  adult 
cells were exposed to the calcium antagonist verapamil (10  -4 M), the response to 
FMLP was very similar to that  of the neonatal  PMN. The results were similar 
when 10% zymosan-activated serum was employed as the chemoattractant. These 
data suggested to us that calcium plays a role in the membrane potential changes 
observed in FMLP-stimulated PMN. 
Additional  studies  were carried  out  using  the  calcium-sensitive  probe  Quin 
2/AM. This dye enters the cytoplasm of cells, after a period of incubation, where 
it is sensitive to changes in the concentration of free calcium (13,  16). As Shown 
in  Fig.  2,  the  PMN  from  10 adult donors  showed a  marked  change  in  Quin 
2/AM  fluorescence following FMLP stimulation  (47-51%).  A  change  in  Quin 
2/AM  fluorescence  was  also  detected  following  FMLP  stimulation  of  PMN 
from  10 healthy, term neonates (Fig. 2). The response was significantly lower (P 
<  0.01-0.05) than  that of the adult PMN at each of the time intervals studied, 
however. Again, the baseline level of fluorescence in neonatal cells was essentially 
the  same  as that  in  adult  cells,  indicating  normal  penetration  of the  dye and 
comparable  levels of free  calcium.  The  responses to  zymosan-activated  serum 
were similar to those using FMLP with adult and neonatal PMN. 
The alteration observed in Quin 2/AM fluorescence emission following stim- 
ulation  of adult and  neonatal  PMN  with  FMLP was not appreciably changed 
when the experiment was carried out in calcium-deprived media to which 2 mM 
EGTA had been added (Fig.  2).  Addition  of the calcium antagonist  verapamil 
(10  -4 M) to the PMN  15 min before FMLP stimulation essentially abolished the 
change  in  free  calcium  levels  observed  in  untreated  adult  or  neonatal  cells 
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FIGURE 2.  Changes in intracellular free calcium in FMLP-stimulated (2.5 ×  10  -s M) PMN 
from l0 adults and 10 neonates as determined by Quin 2/AM fluorescence emission. Calcium- 
containing (1.6 mM) and calcium-deprived (no added calcium +  2  mM  EGTA) media were 
employed as indicated. The bottom lines represent the responses of PMN from 10 adults and 
10 neonates that were incubated with 10  -4 M verapamil for 15 min before FMLP stimulation. 
Discussion 
Adult PMN responded to FMLP stimulation  with a  marked change (31%) in 
membrane potential as measured by DiOCs(3) fluorescence. In striking contrast, 
PMN from neonates showed essentially no change in membrane potential follow- 
ing stimulation  with FMLP. Since calcium is required  for chemotaxis, and this 
cation contributes to changes in membrane potential (11-14), we next assessed 
the  effects of FMLP on changes  in  intracellular  free calcium  in  neonatal  and 
adult PMN. In each instance, PMN from adults and neonates showed significant 
increases in free intracellular calcium, as indicated by Quin 2/AM fluorescence. 
The response of neonatal  PMN was markedly decreased, however, when com- 
pared to that of PMN from adults. 
Chemotaxis is a  function at least partially dependent  upon calcium  (20,  21). 
Korchak and associates (22) have recently indicated that  FMLP produces a  rise 
in  cytosolic calcium  that  is  one  of the  earliest  events in  the  process of PMN 
activation. In fact, they reported that chemotactic levels of FMLP elicited optimal 
increments in cytosolic calcium without triggering degranulation  or superoxide 
production.  We found  that  the  level of extracellular  calcium  did  not directly 
affect membrane  potential  changes (data not shown) and,  surprisingly,  did not 
alter the increase in intracellular  free calcium induced by FMLP. This suggests 
that  the  increase  is  due  mainly  to  mobilization  of membrane  or  intracellular 
calcium  stores.  The  calcium  antagonist  verapamil  blocks calcium  channels  re- 
sponsible for entry of calcium into cells, but also interferes with the release of 
intracellular  calcium  (17-19).  This  agent  completely abolished  the  change  in SACCHI AND  HILL  BRIEF  DEFINITIVE REPORT  1251 
membrane potential observed in adult PMN  exposed to FMLP, making their 
response identical to that of the cells from neonates. Clearly, calcium is not the 
only factor involved, as other ionic events such as sodium and potassium exchange 
may also affect membrane potential and may be abnormal in neonatal PMN. 
Summary 
In an attempt to determine the mechanism of the profound defect in chemo- 
taxis observed in the polymorphonuclear leukocytes (PMN) of human neonates, 
we have examined membrane potential changes and alterations in free intracel- 
lular calcium following chemotactic factor stimulation. Following exposure to 
formyl-methionyl-leucyl-phenylalanine  (FMLP),  PMN  from adult  donors  (11) 
showed  a  marked  change  in  membrane  potential  (31%)  as  determined  by 
fluorescence  emission  using  the  cyanine  dye,  3-3-dipentyloxacarbocyanine 
[DiOCs(3)].  In marked contrast,  FMLP-stimulated PMN from  10  human neo- 
nates failed to show any significant change in membrane potential (1-2%). Using 
the calcium-sensitive probe Quin 2/AM, FMLP induced an increase in fluores- 
cence of up to 51% in adult PMN (10).  In contrast, the change in intracellular 
free calcium induced in neonatal PMN was much less (32%; P  <  0.01).  These 
results suggest that the profound defect in chemotactic responsiveness of PMN 
from human neonates may result from an  inability of these  cells  to  undergo 
changes in membrane potential following inflammatory mediator stimulation. 
We wish to thank Nancy Hogan Augustine  for excellent  technical assistance and Dr. 
Steven Wiley for advice. 
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